Plaque vulnerability Key role of macrophages

Slides:



Advertisements
Similar presentations
Statins as Protective Agents for Aortic Endothelial Cells Robert Kreisberg West Liberty State College.
Advertisements

Atherosclerosis Mike Clark, M.D.. Terms Arteriosclerosis – hardening of the arteries Atherosclerosis – a form of arteriosclerosis Venosclerosis Arteriolosclerosis.
Atherosclerosis.
PBL CV 2 Pathophysiology of coronary artery disease.
Cardiovascular Disease. Learning outcomes Atherosclerosis is the accumulation of fatty material (consisting mainly of cholesterol), fibrous material and.
CHAPTER13 Biomaterials and Thrombosis 13-1 Introduction: Overview of Hemostasis Blood-Biomaterials Interaction via protein coats ---- blood coagulation.
Anatomo-Histology From Table 8.10 Brain atrophy, flattening of gyri,
Aging of the Cardiovascular System (continued)
Extracellular cholesterol and cholesterol-filled macrophages (foam cells) accumulate in subendothelial space. Subsequent structural modifications of LDL.
PATHOLOGY OF VASCULAR OCCLUSION, ATHEROSCLEROSIS, HYPERTENSION AND LYMPHEDEMA.
Biochemical Markers in the inflammatory response Dr Claire Bethune Consultant Immunologist Derriford Hospital.
Dr Azra Parveen Senior Registrar Medicine. Acute myocardial infarction is the rapid development of myocardial necrosis caused by a critical imbalance.
Atherosclerosis.
Antiplatelet Drugs - Principles Benedict R. Lucchesi, M.D., Ph.D. Department of Pharmacology University of Michigan Medical School.
Haemostasis Presented by Dr Azza Serry. Learning Objectives  Definition.  Clotting mechanism.  What keeps blood in fluid status  Control of blood.
Coagulation Mechanisms
Atherosclerosis CVS lecture 2 Atherosclerosis Shaesta Naseem.
Atherosclerosis CVS 1 Hisham Al Khalidi. Atherosclerosis.wmv.
atherosclerosis Jon Yap John A. Burns School of Medicine
Atherosclerosis CVS lecture 2 Atherosclerosis. Vessel wall structure.
Cardiovascular disease 1/Pathology of cardiovascular disease (CVD) - Effect of artherosclerosis and its links to cardiovascular disease (CVD) - Thrombosis.
순환기질환 - 혈관, 림프관 -.
Cardiovascular Disease (CVD) Objectives: Describe the movement of blood through the cardiovascular system Discuss the prevalence of CVD Define the types.
HANDBOOK OF DYSLIPIDEMIA AND ATHEROSCLEROSIS Part One Professor Jean-Charles Fruchart Department of Atherosclerosis (Inserm UR545) Pasteur Institute of.
Atherosclerosis. Atheroma are not merely filled with lipid, but contain cells whose functions critically influence atherogenesis: Intrinsic Vascular Wall.
IN THE NAME OF GOD Disseminated Intravascular Coagulation Dr.h-kayalhaAnesthesiologist.
Venous Thromboembolism-1
Atherosclerosis.
Is atherosclerosis a metabolic disease?
B – The Cardiovascular System
Higher Human Biology Subtopic 15 Cardiovascular Disease
Peter Libby, MD  The American Journal of Medicine 
Design of a Biodegradable Vascular Construct
Mini Lecture 2 Module: Effects of Tobacco on the Cardiovascular System
CLS 223.
Plaque rupture, thrombosis, and healing. A
The pathology of cardiovascular disease (CVD)
L/O – What causes atherosclerosis?
Coronary disease million Cancer Cerebrovascular disease
Ch 13.6: Blood Vessels 13.7: Athrosclerosis and Cardiac Arrhythmias
Focus: Lipids and the endothelium
Figure 1 Mechanism of thrombus formation during ST-segment
Advanced Nutrition Diet and Cardiovascular Disease 1
CLA-1/SR-BI protein may promote cholesterol removal from peripheral cells Figure 84 The CLA-1 receptor is the human homolog of the SR-I receptor in mice.
Statin effect on apo A-I synthesis is related to its mode of action Inhibition by mevalonate Figure 106 If mevalonate is added to cells with statin-induced.
HDL and Atherosclerosis
What do I know? What is atherosclerosis?
Antithrombotic and prothrombotic molecules Content Points:
Answer the 20 questions!.
Chapter 12 Pathophysiology of Atherosclerosis
Arterial wall: structure and function
Section 4: Plaque dynamics and stenosis
Diabetes and atherosclerosis
Drugs Affecting Blood.
Thrombosis and Inflammatory Bowel Disease
Figure 2 Adaptive immunity in atherosclerosis
Lipid core constitution Activated macrophages accumulate lipids
THROMBOSIS.
Atherosclerosis Dr:HAMED ALGHAMDI.
The Biological Role of Inflammation in Atherosclerosis
Macrophages in the Pathogenesis of Atherosclerosis
Endothelial regulation: Understanding RAS
Thrombosis and Embolism
Hemostasis Hemostasis depends on the integrity of Blood vessels
How to reduce the risk of plaque rupture
Impaired Lung Function and Risk for Stroke
Atherosclerosis  Christopher K. Glass, Joseph L. Witztum  Cell 
Trousseau's syndrome: multiple definitions and multiple mechanisms
How I treat disseminated intravascular coagulation
Multiple mechanisms in Trousseau's syndrome.
Presentation transcript:

Plaque vulnerability Key role of macrophages Figure 14 Factors which play a key role in increasing plaque vulnerability. These include: lipid core formation; parietal vascular inflammation; thinning of the fibrous cap; thrombus formation.

Vulnerable plaque Key role of the macrophage in vascular wall inflammation Figure 15 Macrophages play a key role in the formation of a vulnerable plaque. This is achieved because they: liberate cytokines, which cause vascular wall inflammation; produce Tissue Factor (TF), which results in further cell recruitment; decrease fibrous cap resistance.

Fibrinogen is an independent risk factor for atherosclerosis Figure 16 Activated macrophages release pro-inflammatory cytokines (IL-6, IL-1, TNFa). Cytokines increase hepatic fibrinogen expression and hence plasma concentration. The risk of cardiovascular disease increases with increasing fibrinogen concentrations.

Vulnerable plaque Key role of the macrophage in the degradation of the fibrous cap Figure 17 Macrophages weaken the fibrous cap by releasing metalloproteases. This release results in: degradation of the fibrous cap around the lipid core; degradation of connective tissue within the lipid core.

Thrombus formation The macrophages release coagulation factors Figure 18 Activated macrophages increase TF production, which results in: further cell recruitment (monocytes and platelets); increased coagulability, which facilitates thrombosis; increased predisposition to plaque rupture.

Tissue factor: the initiator of coagulation and thrombogenesis in vivo Figure 19 Tissue Factor initiates the coagulation cascade, which culminates in thrombus formation. It is released from platelets and endothelium as well as activated macrophages.

Oxidized LDL and thrombogenesis Figure 20 Oxidized LDL activates macrophages and stimulates TF expression. It also stimulates increased production of plasminogen activator inhibitor type 1 (PAI-1), which inhibits fibrinolysis. The end result is a state of hypercoagulability around the plaque, which plays a major role in thrombus formation during plaque rupture.

Plaque disruption (plaque cracking, fissuring, rupture – thrombosis start point) Figure 21 Plaque rupture produces occlusive thrombosis. The occlusion may be partial (such as a wall thrombus, which is fibrin- and platelet-rich) and gives rise to unstable angina, or complete myocardial infarction (the thrombi of which are thrombin-rich). Partial occlusions are prone to embolization and, as such, can give rise to distal occlusions.